Search - tctmd.com

Displaying 101 - 118 of 118

Sort: Relevancy | Date

Presentation ACC 2013

Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement

Presenter: Philippe Généreux

March 09, 2013

Presentation ACC 2013

A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort

Presenter: Martin B. Leon

March 09, 2013

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Study Looks at Long-term Mortality Predictors in TAVR Patients

Jason Kahn

March 27, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

Presentation ACC 2012

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

Presenter: Susheel K. Kodali

March 26, 2012

News Conference News ACC 2012

CORONARY Bypass Shows Similar Results Whether On-Pump or Off

Jason Kahn

March 26, 2012

News Conference News ACC 2012

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Jason Kahn

March 25, 2012

Presentation ACC 2012

Long-Term Outcomes Following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience

Presenter: Josep Rod?s-Cabau

March 24, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

Video

» Interview

Beyond the Data: The ALIGN-AR Trial

April 18, 2025

Video

» Interview

Beyond the Data: PROTECT-TAVI

March 29, 2025

Video

» Interview

Apixaban After TAVI for Aortic Stenosis: ATLANTIS

May 20, 2021

Video

» Interview

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

April 3, 2022

Video

» Interview

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

March 18, 2019

Video

» Interview

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

March 18, 2019

Video

» Interview

ACC 2019: Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

March 18, 2019

Video

» Interview

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

May 4, 2022

Advertisement

Paravalvular Leaks Post-Transcatheter Aortic Valve Replacement

A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Study Looks at Long-term Mortality Predictors in TAVR Patients

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

Late (≥ 2 year) Clinical and Echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-Risk Cohort of The PARTNER Trial

CORONARY Bypass Shows Similar Results Whether On-Pump or Off

BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy

Long-Term Outcomes Following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Beyond the Data: The ALIGN-AR Trial

Beyond the Data: PROTECT-TAVI

Apixaban After TAVI for Aortic Stenosis: ATLANTIS

ACC 2022: Insights from the CoreValve US Pivotal and SURTAVI Trials: Five-Year Incidence, Timing And Predictors of Hemodynamic Valve Deterioration ff Transcatheter snd Surgical Aortic Bioprostheses

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

ACC 2019: PARTNER 3 - Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

ACC 2019: Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

A Randomized ADAPT-TAVR Trial: Edoxaban Versus Dual Antiplatelet Therapy for Valve Thrombosis and Cerebral Thromboembolism After Transcatheter Aortic-Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content